Ben Franklin Technology Partners of Southeastern Pennsylvania

Houwzer, LLC is a real estate brokerage and home services company based in Philadelphia, Pennsylvania, with additional offices in Washington, D.C., Baltimore, Maryland, and Haddonfield, New Jersey. Founded in 2014, Houwzer offers a comprehensive suite of services for buying and selling homes, including communication tools, industry insights, and transaction management. The company employs salaried agents and mortgage advisors, allowing them to focus on client service rather than commission-driven sales. This innovative model has enabled Houwzer to provide a streamlined, end-to-end platform for home transactions, enhancing the overall customer experience. With a strong emphasis on service quality, Houwzer boasts an industry-leading Net Promoter Score of 84 and an impressive average rating of 4.9 out of 5 stars from numerous client reviews. Since its inception, Houwzer has facilitated the buying and selling of thousands of homes valued at over $1 billion, delivering significant savings for home sellers on the East Coast.

Corridor Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutic small molecule inhibitors of arginase. Its arginase is an enzyme that competes with endothelial nitric oxide synthase for the use of the common substrate l-arginine. The company's arginase also leads to the production of ornithine which increases polyamine, stimulating cell division, and contributing to hyperplasia and fibrosis. Corridor Pharmaceuticals, Inc. was formerly known as Arginetix, Inc. and changed its name to Corridor Pharmaceuticals, Inc. on June 17, 2010. The company was founded in 2007 and is based in Lutherville, Maryland.